Israeli Pharma Giant Teva Buys Botox's Allergan
$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.
Tags
Mylan
News and updates about Mylan
Israeli Pharma Company Teva Looks to Become Global Giant
$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?
PreviousNext